GALAD Model for Hepatocellular Carcinoma (HCC)
Diagnoses HCC based on serum biomarkers in patients with chronic liver disease (CLD).
Result:
Please fill out required fields.
Dr. Philip J. Johnson
About the creator
Philip J. Johnson, MD, FRCP, is a professor in translational oncology at the University of Liverpool. He is also the deputy director of the North West Cancer Research Centre, University of Liverpool. Dr. Johnson’s primary research is focused on diagnosis and prognosis of hepatobiliary and pancreatic cancer.
To view Dr. Philip J. Johnson's publications, visit PubMed
Are you Dr. Philip J. Johnson? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.